Cardiac Aging Research Identifies PRDM16 Heart Regulator

Key Takeaways

• • Researchers created a single-nucleus atlas of the human heart spanning fetal development to older adulthood.
  • Analysis of 442,239 cardiac nuclei revealed age-related shifts in heart muscle cell function and gene expression.
  • PRDM16 emerged as a critical regulator that declines with age.
  • PRDM16 suppression triggered senescence-like changes in human cardiomyocyte models.
  • Overexpressing Prdm16 in aged mice improved cardiac systolic function and reduced aging-associated molecular signatures.
  • Findings may support future precision cardiology and cardiac aging research.
  • For More Updates in Cardiology, register for the ISCC2026 today

Cardiac Aging Research Reveals a Potential Molecular Target

What Causes Age-Related Changes in Heart Muscle Cells?

Cardiac aging remains one of the strongest contributors to cardiovascular disease, yet the cellular mechanisms behind declining heart function have remained unclear. A new study published in Science Advances provides one of the most comprehensive maps of the aging human heart, highlighting PRDM16 as a potential regulator of age-associated cardiac decline.

Researchers analyzed 54 nonfailing heart tissue samples collected from 29 donors across six life stages, ranging from early fetal development to 75 years of age. Using advanced single-nucleus RNA sequencing (snRNA-seq), the team examined 442,239 individual nuclei to track how gene expression patterns change throughout life.

The findings showed that the heart undergoes substantial cellular remodeling long before birth. Proliferative cardiac cells declined sharply during fetal development, suggesting that much of the heart’s regenerative potential is lost before infancy.

How Does PRDM16 Influence Cardiac Aging?

As hearts aged, investigators identified a distinct cardiomyocyte state known as CM4, characterized by increased cellular stress, inflammatory signaling, and senescence-associated secretory phenotype (SASP) activity.

Among the study’s most notable discoveries was the identification of PRDM16, a transcription factor whose activity steadily decreased with age. Lower PRDM16 expression strongly correlated with higher transcriptomic aging scores, suggesting an important role in maintaining cellular homeostasis.

To validate these findings, researchers reduced PRDM16 expression in human-induced pluripotent stem cell-derived cardiomyocytes. The intervention triggered several hallmarks of cellular aging, including elevated levels of p21 and increased production of the inflammatory cytokine interleukin-8. The cells also exhibited metabolic dysfunction and heightened stress responses.

Can PRDM16 Improve Heart Function in Aging Hearts?

Experimental Findings Offer New Directions for Precision Cardiology

The research team next evaluated whether restoring PRDM16 could improve cardiac performance. Using adenoviral gene delivery, they increased Prdm16 expression in aged mice.

Results demonstrated measurable improvements in systolic function, including enhanced ejection fraction and fractional shortening. Researchers also observed reductions in cardiomyocyte hypertrophy and partial reversal of aging-related gene expression patterns.

Additionally, the study generated highly accurate transcriptomic aging clocks capable of estimating biological heart age. These models identified accelerated aging signatures in diseased hearts affected by cardiomyopathies, opening opportunities for age-aware cardiovascular risk assessment.

While additional studies are needed to evaluate sex-specific differences and clinical applicability, the findings position PRDM16 as a promising focus for future investigations into heart aging, cardiomyocyte senescence, and cardiovascular disease prevention.

For More Updates in Cardiology, register for the ISCC2026 today

For healthcare professionals, this extensive transcriptomic atlas offers valuable insights into the molecular mechanisms underlying cardiac aging. It may help inform future therapeutic strategies to preserve heart function later in life.

Source:

Science Advances